Di X - Search Results

1

Therapeutic potential of anti-PIK3CG treatment for multiple myeloma via inhibiting c-Myc pathway.

Di X, Pan Y, Yan J, Liu J, Wen D, Jiang H, Zhang S. Di X, et al. Heliyon. 2023 Dec 6;10(1):e23165. doi: 10.1016/j.heliyon.2023.e23165. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38163179 Free PMC article.

2

Fringe family genes and their modulation of Notch signaling in cancer.

Mugisha S, Di X, Disoma C, Jiang H, Zhang S. Mugisha S, et al. Among authors: di x. Biochim Biophys Acta Rev Cancer. 2022 Jul;1877(4):188746. doi: 10.1016/j.bbcan.2022.188746. Epub 2022 Jun 3. Biochim Biophys Acta Rev Cancer. 2022. PMID: 35660646 Review.

3

Upregulated GATA3/miR205-5p Axis Inhibits MFNG Transcription and Reduces the Malignancy of Triple-Negative Breast Cancer.

Mugisha S, Di X, Wen D, Zhao Y, Wu X, Zhang S, Jiang H. Mugisha S, et al. Among authors: di x. Cancers (Basel). 2022 Jun 22;14(13):3057. doi: 10.3390/cancers14133057. Cancers (Basel). 2022. PMID: 35804829 Free PMC article.

4

The role of zinc finger proteins in malignant tumors.

Zhao J, Wen D, Zhang S, Jiang H, Di X. Zhao J, et al. Among authors: di x. FASEB J. 2023 Sep;37(9):e23157. doi: 10.1096/fj.202300801R. FASEB J. 2023. PMID: 37615242 Review.

5

A novel RBBP8(p.E281*) germline mutation is a predisposing mutation in familial hereditary cancer syndrome.

Yan J, Wu J, Wang Y, Di X, Jiang H, Wen D, Li D, Zhang S. Yan J, et al. Among authors: di x. J Mol Med (Berl). 2023 Oct;101(10):1255-1265. doi: 10.1007/s00109-023-02354-z. Epub 2023 Aug 24. J Mol Med (Berl). 2023. PMID: 37615686

6

Deubiquitinase OTUD3: a double-edged sword in immunity and disease.

Xu Q, He L, Zhang S, Di X, Jiang H. Xu Q, et al. Among authors: di x. Front Cell Dev Biol. 2023 Sep 26;11:1237530. doi: 10.3389/fcell.2023.1237530. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37829187 Free PMC article. Review.

7

Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/STAT3 Complex.

Jiang H, Wang Y, Wen D, Yu R, Esa SS, Lv K, Feng Q, Liu J, Li F, He L, Di X, Zhang S. Jiang H, et al. Among authors: di x. Adv Sci (Weinh). 2024 Apr;11(15):e2306623. doi: 10.1002/advs.202306623. Epub 2024 Feb 11. Adv Sci (Weinh). 2024. PMID: 38342622 Free PMC article.

8

Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.

Di X, Wang D, Wu J, Zhu X, Wang Y, Yan J, Wen L, Jiang H, Wen D, Shu B, Zhang S. Di X, et al. Gene. 2024 May 25;908:148304. doi: 10.1016/j.gene.2024.148304. Epub 2024 Feb 21. Gene. 2024. PMID: 38387708

9

Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment.

Wang F, Lu S, Zhou X, Di X, Wu R, Chen G, Tian S. Wang F, et al. Among authors: di x. Front Immunol. 2023 Mar 23;14:1103741. doi: 10.3389/fimmu.2023.1103741. eCollection 2023. Front Immunol. 2023. PMID: 37033948 Free PMC article.

10

Development and function of central cell in angiosperm female gametophyte.

Liu Y, Yan Z, Chen N, Di X, Huang J, Guo G. Liu Y, et al. Among authors: di x. Genesis. 2010 Aug;48(8):466-78. doi: 10.1002/dvg.20647. Genesis. 2010. PMID: 20506265 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

793 results

Search Page